"Almost all of the 41 million estimated contact lens wearers in the United States may be engaging in at least one behavior known to increase their risk of eye infections, according to a report published today by the Centers for Disease Control and"...
Prolensa Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Prolensa (bromfenac) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat eye pain that arises as the result of cataract surgery. Common side effects of Prolensa include light sensitivity, watery eyes, the feeling that there is a foreign object in the eye, eye pain or irritation, eye itching, and blurred vision.
Prolensa is generally dosed as one drop into the affected eye one day before surgery. Prolensa should also be used on the day of eye surgery, as well as for 14 days following. Discuss the dosing and usage with your doctor. Prolensa may be used alongside other topical eye medications. Each additional medication should be given at least five minutes apart. Prolensa may interact with other drugs. Tell your doctor all medications you use. Prolensa contains sodium sulfite, which may produce severe allergic reactions and life-threatening or severe asthma attacks in certain people. The use of Prolensa may slow healing. Prolensa should be given to a pregnant woman only if the benefit to the mother justifies and potential risk to the fetus. The use of Prolensa in late pregnancy should be avoided. Prolensa should be given to a breastfeeding mother under strict caution.
Our Prolensa (bromfenac) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Prolensa FDA Prescribing Information: Side Effects
Clinical Trial Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
The most commonly reported adverse reactions following use of PROLENSA following cataract surgery include: anterior chamber inflammation, foreign body sensation, eye pain, photophobia, and vision blurred. These reactions were reported in 3 to 8% of patients.
Read the entire FDA prescribing information for Prolensa (Bromfenac Ophthalmic Solution)
Additional Prolensa Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.